XBiotech (XBIT) Capital Expenditures (2014 - 2025)
XBiotech (XBIT) posted quarterly Capital Expenditures of -$255000.0 for Q4 2025, down 498.44% year-over-year from $64000.0 in Q4 2024, and down 331.82% quarter-over-quarter from $110000.0 in Q3 2025.
XBiotech (XBIT) Capital Expenditures (2014 - 2025) Analysis & Trends
XBiotech's Capital Expenditures history runs 12 years deep, the most recent figure standing at -$255000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures fell 498.44% year-over-year to -$255000.0; the TTM figure through Sep 2025 stood at $319000.0 (up 243.69% YoY), while the FY2024 annual figure was $70000.0, up 268.42% from the prior year.
- Capital Expenditures for Q4 2025 stood at -$255000.0, down from $110000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $2.2 million in Q2 2021, with the low at -$3.0 million in Q4 2021.
- The 5-year median for Capital Expenditures is $73500.0 (2022), against an average of $10000.0.
- The sharpest annual moves came in 2021 and 2024: Capital Expenditures surged 6953.12% in 2021, then sank 2754.55% in 2024.
- XBiotech's Capital Expenditures stood at -$3.0 million in 2021, then jumped by 85.28% to -$435000.0 in 2022, then surged by 47.59% to -$228000.0 in 2023, then soared by 128.07% to $64000.0 in 2024, then plunged by 498.44% to -$255000.0 in 2025.
- Business Quant data shows XBIT's Capital Expenditures at -$255000.0 in Q4 2025, $110000.0 in Q3 2025, and $51000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 34.68 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.26 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 251.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -73.57 Mn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -255,000.00 |
| Dec 31, 2025 | -255,000.00 |
| Sep 30, 2025 | 110,000.00 |
| Sep 30, 2025 | 110,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | -876,000.00 |
| Sep 30, 2024 | -876,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Dec 31, 2023 | -228,000.00 |
| Dec 31, 2023 | -228,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |